The Centers for Disease Control and Prevention (CDC) on Tuesday confirmed that it is investigating the death of a woman who received the single-dose Johnson & Johnson COVID-19 vaccine, as part of its investigation into possible adverse events linked to the vaccine.
“No additional details will be provided during the investigation,” Danny Avula, the vaccination coordinator for the state of Virginia, said in a statement.
The Epoch Times has reached out to Johnson & Johnson for comment.
President Joe Biden asserted on Tuesday that the pause will not affect the the supply of vaccines available to Americans.
When asked to comment about the Johnson & Johnson vaccine pause, Biden told reporters, “My message to the American people on the vaccine is, I told you all,” adding that he “made sure we have 600 million doses” of other vaccines—Pfizer and Moderna—available.
“So there’s enough vaccine that is basically 100 percent unquestionable for every single, solitary American,” he said.
Jeff Zients, White House COVID-19 response coordinator, told reporters that the FDA and CDC’s announcement “will not have a significant impact” on the administration’s vaccination plan.
“The J&J vaccine makes up less than 5 percent of the more than 190 million recorded shots in arms in the United States to date,” he said. “And that’s why the President took action earlier this year, before the J&J vaccine was even authorized, to secure enough Pfizer and Moderna doses for 300 million Americans by the end of July.”
Zients said the administration has supply of Pfizer and Moderna vaccines to administer about 3 million shots per day.
“We’re now working with our state and federal partners to get anyone scheduled for a J&J vaccine quickly rescheduled for a Pfizer or Moderna vaccine,” he said. “And we’re actually already seeing this happen today at sites across the country where J&J appointments are being adjusted, that were for today, to actually get Moderna and Pfizer today. So that’s happening in many places across the country.”
“Our close tracking of side effects has revealed a small number of very rare events following vaccination. At present, no clear causal relationship has been established between these rare events and the Janssen COVID-19 vaccine.” Janssen is owned by Johnson & Johnson.